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be started promptly after the diagnosis of drug-induced
acute interstitial nephritis to avoid subsequent interstitial
fibrosis (that rapidly replaces, in the absence of steroids,
the interstitial cellular infiltrates typical of drug-induced
acute interstitial nephritis) and an incomplete recovery of
renal function.
1. Gonza´lez E, Gutie´rrez E, Galeano C et al. Early steroid treatment improves
the recovery of renal function in patients with drug-induced acute
interstitial nephritis. Kidney Int 2008; 73: 940–946.
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We write with reference to the recently published manuscript
by Jorsal et al.1 They observe an association between genetic
variation within the adiponectin gene (rs17300539, G4A
variant) and nephropathy in a cross-sectional study. The A
allele frequency was 0.094 in the nephropathy group
compared to 0.066 in those with normoalbuminuria
(P¼ 0.01). Furthermore, the authors have previously ob-
served this association in another larger study where the A
allele was associated with an approximate 50% increase in
nephropathy risk.2
We have also examined this association. Sex-matched
samples were genotyped from 98 patients with type 1
diabetes (T1DM) and nephropathy,3 99 patients with
T1DM without nephropathy (Golden Years protected
patients)4 and 42 controls. The Golden Years patients have
had T1DM for at least 50 years and so are at extremely low
risk of renal complications. These patients were significantly
older (mean age of 82 years) and had a longer duration of
diabetes (66.9 years) compared to those with nephropathy
(58 years of age and 40 years duration), and controls (55
years of age). As shown in Table 1, we observed that the
frequency of the rare allele (A) was twice as high in those with
nephropathy (0.152) compared to those without (0.078),
P¼ 0.01. The odds ratio for nephropathy associated with the
A allele within the combined groups was 2.12 (95% CI
0.86–5.23), P¼ 0.02.
Our data replicate the previous associations described for
this gene variant. Further, prospective work is essential to
confirm this association.
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Table 1 | Genotype distribution of the rs17300539, G to A
variant in relation to nephropathy
Allele
Nondiabetic
controls
Golden Years
T1DM
Nephropathy
T1DM
GG 38 83 69
GA 3 15 28
AA 1 1 1
Hardy–Weinberg
P-value
0.22 0.73 0.31
Rare allele (A)
frequency
0.06* 0.086+ 0.152*,+
95% CI 0.01–0.11 0.05–0.12 0.1–0.2
T1DM, type 1 diabetes mellitus.
*Po0.01, +Po0.05.
Nephropathic vs combined Golden Years and controls, P=0.01. No difference was
observed in genotype distribution between Golden Years and controls.
Kidney International (2008) 74, 1358–1361 1361
l e t t e r t o t h e e d i t o r
